IBD co-medication prescribed, other than TNF- α inhibitors, were prednisolone (n = 1, < 10 mg/day orally) and rectal corticosteroids and/or 5-ASA applications (n = 2). This evidence concerns the gene TNF and inflammatory bowel disease.